Literature DB >> 15262983

Inhibition of JNK2 disrupts anaphase and produces aneuploidy in mammalian cells.

Rebecca A MacCorkle1, Tse-Hua Tan.   

Abstract

The JNK family members JNK1 and JNK2 regulate tumor growth and are essential for transformation by oncogenes such as constitutively activated Ras. The mechanisms downstream of JNK that regulate cell cycle progression and transformation are unclear. Here we show that inhibition of JNK2, but not JNK1, with either a dominant-negative mutant, a pharmacological inhibitor, or RNA interference caused an accumulation of mammalian cells with 4N DNA content. When observed by immunofluorescence, these cells progressed to metaphase without apparent defects in spindle formation or chromosome alignment to the metaphase plate, suggesting that the 4N accumulation is a result of postmetaphase defects. Consistent with this prediction, when JNK activity was suppressed, we observed defects in central spindle formation and chromosome segregation during anaphase. In contrast, cyclin-dependent kinase 1 activity, cyclin B1 protein, and Polo-like kinase 1 protein turnover remained intact when JNK was inhibited. In addition, continued inhibition of JNK activity did not block reentry into subsequent cell cycles but instead resulted in polyploidy. This evidence suggests that JNK2 functions in maintaining the genomic stability of mammalian cells by signaling that is independent of cyclin-dependent kinase 1/cyclin B1 down-regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262983     DOI: 10.1074/jbc.M405481200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry and G(2)/M DNA damage checkpoint.

Authors:  Gustavo J Gutierrez; Toshiya Tsuji; Janet V Cross; Roger J Davis; Dennis J Templeton; Wei Jiang; Ze'ev A Ronai
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

2.  Opposing roles for JNK and Aurora A in regulating the association of WDR62 with spindle microtubules.

Authors:  Nicholas R Lim; Yvonne Y C Yeap; Teresa T Zhao; Yan Y Yip; Shu C Wong; Dan Xu; Ching-Seng Ang; Nicholas A Williamson; Zhiheng Xu; Marie A Bogoyevitch; Dominic C H Ng
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

3.  Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.

Authors:  Maria E Gonzalez; Olga Makarova; Esther A Peterson; Lisa M Privette; Elizabeth M Petty
Journal:  Cell Signal       Date:  2008-11-18       Impact factor: 4.315

4.  Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.

Authors:  Peila Chen; Jamye F O'Neal; Nancy D Ebelt; Michael A Cantrell; Shreya Mitra; Azadeh Nasrazadani; Tracy L Vandenbroek; Lynn E Heasley; Carla L Van Den Berg
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

5.  Kinesin-1 regulates microtubule dynamics via a c-Jun N-terminal kinase-dependent mechanism.

Authors:  Vanessa Daire; Julien Giustiniani; Ingrid Leroy-Gori; Mélanie Quesnoit; Stéphanie Drevensek; Ariane Dimitrov; Franck Perez; Christian Poüs
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

6.  FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness.

Authors:  I-Ching Wang; Yi-Ju Chen; Douglas E Hughes; Timothy Ackerson; Michael L Major; Vladimir V Kalinichenko; Robert H Costa; Pradip Raychaudhuri; Angela L Tyner; Lester F Lau
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

7.  SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition.

Authors:  J A Kim; J Lee; R L Margolis; R Fotedar
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

Review 8.  Linking JNK Activity to the DNA Damage Response.

Authors:  Vincent Picco; Gilles Pagès
Journal:  Genes Cancer       Date:  2013-09

Review 9.  The functional contrariety of JNK.

Authors:  Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2007-08       Impact factor: 4.784

10.  Selective killing of p53-deficient cancer cells by SP600125.

Authors:  Mohamed Jemaà; Ilio Vitale; Oliver Kepp; Francesco Berardinelli; Lorenzo Galluzzi; Laura Senovilla; Guillermo Mariño; Shoaib Ahmad Malik; Santiago Rello-Varona; Delphine Lissa; Antonio Antoccia; Maximilien Tailler; Frederic Schlemmer; Francis Harper; Gérard Pierron; Maria Castedo; Guido Kroemer
Journal:  EMBO Mol Med       Date:  2012-03-21       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.